Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R33 AI119339
NIAID NIH HHS
Grant: R01 AI141202
National Institutes of Health
Grant: 4R33AI119339-03
Arf6 Inhibition as Novel Treatment for Multidrug Resistance Gram Negative Infections
National Institutes of Health
Grant: 1R01AI141202-01
Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens
National Institutes of Health
FWCI
0.84
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals